Year: 2023

BES_Mark

FARFETCH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Farfetch Limited and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action...

Pfizer_Logo_Color_RGB_APPROVED

PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer

– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found PADCEV plus pembrolizumab nearly doubled...

logo-24

Global Manufacturing Execution Systems (MES) Strategic Market Report, 2022 and 2023-2030: Rapidly Changing Dynamics in the Process & Discrete Manufacturing Environments Necessitate MES Deployments – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Manufacturing Execution Systems (MES) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Manufacturing Execution...

Takeda_Logo-2

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

If Approved, HYQVIA Would Offer an up to Once-Monthly Facilitated Subcutaneous At-Home or In-Office Treatment Option Positive Opinion Based on...